COVID-19 Versus Neurological Impairment, Physical Activity, Social Contacts and Education
NCT ID: NCT04934085
Last Updated: 2021-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2021-06-30
2021-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Developing an Effective Intervention to Address Post-Corona-Virus-Disease-2019 Balance Disorders, Weakness and Muscle Fatigue in Individuals Aged 65+
NCT05934279
The Effect of Physical Fatigue on Different Balance Tests and Brain Activity in a Healthy Population
NCT04030390
Cognitive Motor Interference Rehabilitation in Persons With Multiple Sclerosis
NCT02274935
Balance Function in Patients Post Corona Virus Disease 2019 (COVID-19)
NCT04914364
From Movement Preparation to Gait Execution in ALS
NCT01874808
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* study group (subjects who had tested positive and recovered from COVID-19)
* control group (healthy subjects who did not have COVID-19). The controls will be matched to the study group for gender and age.
The examination will be performed once, at the premises of the University of Rzeszów. The participants' condition will be assessed using the following measures:
* static and dynamic balance and risk of falls (force plate and computerised posturography, clinical tests)
* activity in the cerebral cortex of the frontal lobe during focused performance of a task (Hemoencephalography HEG-System)
* concentration and attention, memory and cognitive functions (Bourdon-Wiersma test and Auditory-Verbal Learning Test)
* gait velocity and efficiency (10-meter walk test and 6-minute walk test)
* physical activity (International Physical Activity Questionnaire IPAQ), as well as education, mood, and social contacts (specially designed questionnaire)
* quality of life (SF-36 questionnaire)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
subjects who had tested positive and recovered from COVID-19
No interventions assigned to this group
Control group
healthy subjects who did not have COVID-19, the controls will be matched to the study group for gender and age
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Experienced infection with SARS-COV-2.
* Age 19 - 26 years
* No injuries to lower limbs in the period of 12 months preceding the date of enrolment into the study
* No orthopaedic disorders affecting the lower limbs (including decreased length of the lower limbs)
* No diagnosed neurological diseases or disorders (including labyrinth dysfunction)
* No diagnosed impairment of concentration and attention
Exclusion Criteria
* No experience of infection with SARS-COV-2
* Age outside the range of 19 and 27 years
* Confirmed injuries to lower limbs in the period of 12 months preceding the date of enrolment into the study
* Confirmed neurological diseases or disorders, such as impaired balance, concentration and attention.
19 Years
26 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rzeszow
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Agnieszka Guzik, PhD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Agnieszka Guzik, PhD
Role: STUDY_CHAIR
University of Rzeszow
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rzeszów
Rzeszów, Podkarpackie Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVID-19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.